Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DIATREME RESOURCES LIMITED Capital/Financing Update 2021

Sep 13, 2021

64787_rns_2021-09-13_ba7cd587-862d-4f7a-8de9-07584b850b4b.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [351 x 83] intentionally omitted <==

==> picture [188 x 63] intentionally omitted <==

Company Announcement Office Australian Securities Exchange Level 4, 20 Bridge Street Sydney NSW 2000

14 September 2021

COMPLETION OF PLACEMENT

Diatreme Resources Limited (ASX: DRX) (“ Diatreme ” or “ Company ”) is pleased to announce it has completed the placement program, as announced to market on 6 September 2021.

Following completion of the placement the Company has now received total funds (before costs) of $10,080,001 (“ Placement ”) through the issue of 438,260,914 fully paid ordinary shares at $0.023 per share (“ Placement Shares ”). The Placement Shares will be issued on the same terms and rank equally in all respects with the existing fully paid ordinary shares in the Company. The allotment of the new shares is not subject to shareholder approval and will fall within the Company’s existing capacity under ASX Listing Rule 7.1 (386,318,497 million shares) and 7.1A (51,942,417 million shares).

An appendix 2A to apply for the quotation of the Placement Shares accompanies this announcement.

This announcement has been authorised for release by the Company Secretary. Please contact the Company Secretary on +61 7 3397 2222 or [email protected] if you have any queries.

Tuan Do Company Secretary

==> picture [545 x 71] intentionally omitted <==